203 related articles for article (PubMed ID: 34095084)
41. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Wang S; Ding Y; Yao Y
Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
[TBL] [Abstract][Full Text] [Related]
42. Characterization and antioxidant activity of the complexes of tertiary butylhydroquinone with β-cyclodextrin and its derivatives.
Pu H; Sun Q; Tang P; Zhao L; Li Q; Liu Y; Li H
Food Chem; 2018 Sep; 260():183-192. PubMed ID: 29699660
[TBL] [Abstract][Full Text] [Related]
43. Inclusion complexes of quercetin with three β-cyclodextrins derivatives at physiological pH: spectroscopic study and antioxidant activity.
Liu M; Dong L; Chen A; Zheng Y; Sun D; Wang X; Wang B
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():854-60. PubMed ID: 23892509
[TBL] [Abstract][Full Text] [Related]
44. Cyclodextrin derivatives in pharmaceutics.
Albers E; Müller BW
Crit Rev Ther Drug Carrier Syst; 1995; 12(4):311-37. PubMed ID: 9501966
[TBL] [Abstract][Full Text] [Related]
45. Propyl gallate/cyclodextrin supramolecular complexes with enhanced solubility and radical scavenging capacity.
Li Q; Pu H; Tang P; Tang B; Sun Q; Li H
Food Chem; 2018 Apr; 245():1062-1069. PubMed ID: 29287323
[TBL] [Abstract][Full Text] [Related]
46. Complexation of steroid hormones with cyclodextrin derivatives: substituent effects of the guest molecule on solubility and stability in aqueous solution.
Albers E; Müller BW
J Pharm Sci; 1992 Aug; 81(8):756-61. PubMed ID: 1403720
[TBL] [Abstract][Full Text] [Related]
47. The counteracting influence of 2-hydroxypropyl substitution and the presence of a guest molecule on the shape and size of the β-cyclodextrin cavity.
Sandilya AA; Priya MH
Phys Chem Chem Phys; 2024 Apr; 26(15):11531-11544. PubMed ID: 38323885
[TBL] [Abstract][Full Text] [Related]
48. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
[TBL] [Abstract][Full Text] [Related]
49. Structural insights into the inclusion complexes between clomiphene citrate and β-cyclodextrin: The mechanism of preferential isomeric selection.
Maheshwari A; Saraswat H; Upadhyay SK
Chirality; 2017 Aug; 29(8):451-457. PubMed ID: 28644553
[TBL] [Abstract][Full Text] [Related]
50. Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs.
Müller BW; Albers E
J Pharm Sci; 1991 Jun; 80(6):599-604. PubMed ID: 1834826
[TBL] [Abstract][Full Text] [Related]
51. Dispersion-corrected DFT calculations and umbrella sampling simulations to investigate stability of Chrysin-cyclodextrin inclusion complexes.
Kumar P; Bhardwaj VK; Purohit R
Carbohydr Polym; 2023 Nov; 319():121162. PubMed ID: 37567706
[TBL] [Abstract][Full Text] [Related]
52. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
[TBL] [Abstract][Full Text] [Related]
53. The effect of complexation with cyclodextrins on the antioxidant and antimicrobial activity of ellagic acid.
Savic IM; Jocic E; Nikolic VD; Popsavin MM; Rakic SJ; Savic-Gajic IM
Pharm Dev Technol; 2019 Apr; 24(4):410-418. PubMed ID: 30035651
[TBL] [Abstract][Full Text] [Related]
54. Solubility enhancement of poorly water soluble domperidone by complexation with the large ring cyclodextrin.
Ismail A; Kerdpol K; Rungrotmongkol T; Tananuwong K; Ueno T; Ekasit S; Muangsin N; Krusong K
Int J Pharm; 2021 Sep; 606():120909. PubMed ID: 34298103
[TBL] [Abstract][Full Text] [Related]
55. Effect of pH on the complexation of kaempferol-4'-glucoside with three β-cyclodextrin derivatives: isothermal titration calorimetry and spectroscopy study.
Zheng Y; Dong LN; Liu M; Chen A; Feng S; Wang B; Sun D
J Agric Food Chem; 2014 Jan; 62(1):244-50. PubMed ID: 24308546
[TBL] [Abstract][Full Text] [Related]
56. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins.
Zannou EA; Streng WH; Stella VJ
Pharm Res; 2001 Aug; 18(8):1226-31. PubMed ID: 11587496
[TBL] [Abstract][Full Text] [Related]
57. Application of sodium sulfobutylether-β-cyclodextrin based on encapsulation.
Huang J; Wang X; Huang T; Yang Y; Tu J; Zou J; Yang H; Yang R
Carbohydr Polym; 2024 Jun; 333():121985. PubMed ID: 38494236
[TBL] [Abstract][Full Text] [Related]
58. Molecular recognition in cyclodextrin complexes of amino acid derivatives. 2. A new perturbation: the room-temperature crystallographic structure determination for the N-acetyl-p-methoxy-L-phenylalanine methyl ester/beta-cyclodextrin complex.
Clark JL; Booth BR; Stezowski JJ
J Am Chem Soc; 2001 Oct; 123(40):9889-95. PubMed ID: 11583553
[TBL] [Abstract][Full Text] [Related]
59. Comparative study on the inclusion behavior between meso-tetrakis(4-N-ethylpyridiniurmyl)porphyrin and beta-cyclodextrin derivatives.
Xiliang G; Shaomin S; Chuan D; Feng F; Wong MS
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(3):413-8. PubMed ID: 15582808
[TBL] [Abstract][Full Text] [Related]
60. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
